Zai Lab Files for $115 Million IPO in the US

Aug 16, 2017

Life Science

Lilly Asia Ventures Closes Fourth Fund with $450 Million

Aug 15, 2017

Life Science

China’s Fosun, Shanghai Pharma say bid for stake in U.S. drugmaker Arbor

Aug 15, 2017

Life Science

Shenzhen Royal Asset to Pay $33 Million for Fibrosis Candidates from Prometic

Aug 14, 2017

Life Science

Zai Lab of Shanghai Plans $150 Million IPO in the US

Aug 11, 2017

Life Science

Fosun and Shanghai Pharmas Competing for $700 Million Stake in US-based Arbor

Aug 11, 2017

Life Science

RedHill Biopharma Provides 2017 Semi-Annual Business Update

Aug 11, 2017

Life Science

RedHill Biopharma Provides 2017 Semi-Annual Business Update

Aug 10, 2017

Life Science

Biocept Raises $2.2 Million from Ally Bridge; Plans China Expansion

Aug 10, 2017

Life Science

New Horizon Raises $20 Million for Diagnostics in Qiming-Led B Round

Aug 9, 2017

Life Science

Shenzhen Salubris May Acquire Liver Cancer Candidate from US NIH

Aug 9, 2017

Life Science

Shanghai Pharma Negotiating with DHL on Global Drug Distribution

Aug 8, 2017

Life Science

Hangzhou Just Bio Raises $57 Million for Biologic Drug Development

Aug 8, 2017

Life Science

Korea’s ViroMed Starts Trial of Gene Therapy for Diabetic Foot Ulcers

Aug 4, 2017

Life Science

GSK To Close Shanghai Neurological R&D Operations

Aug 3, 2017

Life Science

Bayer Offers Concessions to EU Commission for Monsanto Deal

Aug 2, 2017

Life Science, Others

Chi-Med’s Innovative Drug Portfolio: Eight Candidates in 31 Trials

Aug 2, 2017

Life Science

UCL-developed stem therapy culled from Pfizer’s pipeline

Aug 1, 2017

Life Science